ARCHIVES

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

This article is from The Cancer Letter archive.

Vol. 21 No. 08 | February 24, 1995

Download PDF Visit The Full Archive

Related Articles

Friends Of Cancer Research Plan September Launch

August 9, 1996

Dear FDA: Provenge Provokes Letters From Opponents, Advocates, Investors.

April 27, 2007

Trials Approved by NCI CTEP For the Month of April

April 27, 2012

In Brief: Salmon Heads AACI, Owens President Elect; AMA Adds PDQ To Its Electronic Network

June 30, 1989

“Sloppy” Cancer Control Grant Applications Turned Down At Twice NIH Disapproval Rate

November 7, 1975

The FY 1984 Bypass Budget: How NCI Would Spend the Money

July 9, 1982